Immunohistochemical characterisation of pulmonary hyaline membrane in various types of interstitial pneumonia

Pathology

Volumn 35, Issue 2, 2003, Pages 120-124

  Sun, A Ping ^a   Ohtsuki, Yuji ^a   Fujita, Jiro ^b   Ishida, Toshihiko ^b   Yoshinouchi, Takeo ^c   Kohno, Nobuoki ^d  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

^c NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^d HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Diffuse alveolar damage; Heterogeneity; Hyaline membrane; Immunohistochemistry; Interstitial pneumonia

Indexed keywords

ANTIBODY; APOLIPOPROTEIN A; BLOOD CLOTTING FACTOR 8; CYTOKERATIN; CYTOKERATIN 19; EPITHELIAL MEMBRANE ANTIGEN; FIBRIN; M PROTEIN; VON WILLEBRAND FACTOR;

ACUTE DISEASE; ADULT; AGED; ARTICLE; CELL HETEROGENEITY; CLINICAL ARTICLE; DERMATOMYOSITIS; DIAGNOSTIC KIT; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; HYALINE MEMBRANE DISEASE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTERSTITIAL PNEUMONIA; LUNG ALVEOLUS; MALE; MEDICAL EXAMINATION; PRESCHOOL CHILD; RHEUMATOID ARTHRITIS; SERUM FACTOR; STAINING; SYSTEMIC SCLEROSIS; TISSUE SECTION; VIRUS INFECTION;

EID: 0038289114     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/00313020307572     Document Type: Article

References (22)

1. Crystal RG, Gadek JE, Ferrans VJ, Fulmer JD, Line BR, Hunninghake GW. Interstitial lung disease: current concepts of pathogenesis, staging, and therapy. Am J Med 1981; 70: 542-68.
2. Crystal RG, Fulmer JD, Roberts WC, Moss ML, Line BR, Reynolds HY. Idiopathic pulmonary fibrosis: clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects. Ann Intern Med 1976; 85: 769-88.
3. Crystal RG, Bitterman PB, Rennard SI, Hence AJ, Keogh BA. Interstitial lung diseases of unknown cause. N Engl J Med 1984; 310: 154-66.
4. Schwarz MI. Approach to the understanding, diagnosis, and management of interstitial lung disease. In: Schwarz MI, King TE Jr, editors. Interstitial Lung Disease. 3rd ed. Hamilton: BC Decker Inc, 1992; 3-30.
5. Hamman L, Rich AR. Acute diffuse interstitial fibrosis of the lungs. Bull Johns Hopkins Hosp 1944; 74: 177-212.
6. Katzenstein AL, Myers JL, Mazur MT. Acute interstitial pneumonia. A clinicopathologic, ultrastructural, and cell kinetic study. Am J Surg Pathol 1986; 10: 256-67.
7. Kondo A, Saiki S. Acute exacerbation in idiopathic interstitial pneumonia. In: Harasawa M, Fukuchi Y, editors. Interstitial Pneumonia of Unknown Etiology. Tokyo: University of Tokyo Press, 1989; 33-42.
8. Kawanami O, Ferrans VJ, Crystal RG. Structure of alveolar epithelial cells in patients with fibrotic lung disorders. Lab Invest 1982; 46: 39-53.
9. Nadji M, Gonzalez M, Castro A. Factor VIII-related antigen: An endothelial cell marker. Lab Invest 1980; 42: 43 (Abstr).
10. Dobashi N, Fujita J, Ohtsuki Y, et al. Detection of anti-cytokeratin 8 antibody in the serum of patients with cryptogenic fibrosing alveolitis ad pulmonary fibrosis associated with collagen vascular disorders. Thorax 1998; 53: 969-74.
11. Fujita J, Dobashi N, Ohtsuki Y, et al. Elevation of anti-cytokeratin 19 antibody in sera of the patients with idiopathic pulmonary fibrosis and pulmonary fibrosis associated with collagen vascular disorders. Lung 1999; 177: 311-9.
12. Dobashi N, Fujita J, Murota M, et al. Elevation of anti-cytokeratin 18 antibody and circulating cytokeratin 18: Anti-cytokeratin 18 antibody immune complexes in sera of patients with idiopathic pulmonary fibrosis. Lung 2000; 178: 171-9.
13. Coulombe PA. The cellular biology of keratins: beginning a new year. Curr Opin Cell Biol 1993; 5: 17-29.
14. Fuchs E. Keratins as biochemical markers of epithelial differentiation. Trends Genet 1983; 4: 277-81.
15. Moll R, Fanke WW, Schiller DL. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982; 31: 11-24.
16. Steinert PM. Structure, function, and dynamics of keratin intermediate filaments. J Invest Dermatol 1993; 100: 729-34.
17. Gum ET, Dahiya R, Kim YS. Heterogeneity of mucin gene expression in normal and neoplastic tissues. Cancer Res 1993; 539: 641-51.
18. Kohno N, Akiyama M, Kyoizumi S, Hakoda M, Kobuke K, Yamakido M. Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma. Jpn J Clin Oncol 1988; 18: 203-15.
19. Kohno N, Inoue Y, Hamada H, et al. Difference in serodiagnositic values among KL-6-associated mucin classified as cluster 9. Int J Cancer 1994; 8 (Suppl): 81-3.
20. Kohno N, Kyoizumi S, Awaya Y, Fukuhata H, Yamakido M, Akiyama M. New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6. Chest 1989; 96: 68-73.
21. Kohno N, Awaya Y, Oyama T, et al. KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease. Am Rev Respir Dis 1993; 148: 637-42.
22. Hirasawa Y, Kohno N, Yokoyama A, Inoue Y, Abe M, Hiwada K. KL-6, a human MUC1 mucin, is chemotactic for human fibroblasts. Am J Respir Cell Mol Biol 1997; 17: 501-7.